← 返回

LEF1 在 iNKT 细胞中创造记忆,从而增强抗肿瘤免疫

英文原题:LEF1 Creates Memories in iNKT Cells That Potentiate Antitumor Immunity.

查看英文原题

LEF1 Creates Memories in iNKT Cells That Potentiate Antitumor Immunity.

PubMed 2023/02/03(内容时间) Cancer Immunol Res Q1 · IF 7.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

恒定自然杀伤T(iNKT)细胞是先天样T细胞的一个亚群,在开发癌症免疫疗法方面具有巨大潜力,包括基于嵌合抗原受体(CAR)的方法。在本期,Ngai及其同事报道,转录因子淋巴增强结合因子1(LEF1)优化了iNKT细胞促进抗肿瘤免疫的功能特性,这提高了人们对开发基于CAR修饰iNKT细胞的稳健癌症免疫疗法的热情。参见Ngai等人的相关文章,第171页(2)。

展开英文摘要原文

Invariant natural killer T (iNKT) cells are a subset of innate-like T cells with great potential for developing cancer immunotherapies, including approaches based on chimeric antigen receptors (CAR). In this issue, Ngai and colleagues report that the transcription factor lymphoid enhancer-binding factor 1 (LEF1) optimizes functional properties of iNKT cells that promote antitumor immunity, raising enthusiasm for the development of robust cancer immunotherapies based on CAR-modified iNKT cells. See related article by Ngai et al., p. 171 (2).

论文信息

作者
Van Kaer L
单位
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.United States
文献类型
评论
期刊
Cancer immunology research2023 Feb 3
原文标识
PubMed 36630221 · DOI 10.1158/2326-6066.CIR-22-0902